arrow
O

Omar I. Vivar

gustave roussy
H指数:10
被引数:658

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity

放射增敏剂NBTXR3:连接物理学与生物学以改善放射治疗效果并启动抗肿瘤免疫

2025-12-170
OAAI
Radioenhancing Hafnium Oxide Nanoparticles (NBTXR3) Followed by Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Liver Metastases (NBTXR3-103): Phase 1 Dose-Escalation Trial

放射增敏氧化铪纳米颗粒(NBTXR3)后联合立体定向体放射疗法治疗肝细胞癌和肝转移患者(NBTXR3-103):1期剂量递增试验

2025-12-010
OA
Final and exploratory results of a phase I trial evaluating novel radioenhancer NBTXR3 activated by radiotherapy in cisplatin-ineligible LA HNSCC patients

I期临床试验的最终和探索性结果,评估由放疗激活的新型放射增敏剂NBTXR3在顺铂不耐受的局部晚期头颈鳞癌(LA HNSCC)患者中的疗效。

2024-12-010
PRE
Phase I study of endoscopic ultrasound (EUS)-guided NBTXR3 delivery activated by radiotherapy (RT) for locally advanced or borderline resectable pancreatic cancer (LAPC or BRPC)
2024-01-160
PRE